Principal Scientist – Extractables & Leachables (E&L) - Multiple Teams
About the job
- A PhD with at least 10 years of experience or a Master's degree with at least 12 years of experience.
- Be a recognized global expert in Extractables & Leachables, materials science, or a related field, with a strong track record such as publications, patents, or presentations.
- Have deep expertise in Extractables & Leachables science, polymer or material chemistry and/or biopharmaceutical processes, and toxicological and safety assessment concepts.
- Have a strong understanding of Good Manufacturing Practice, pharmaceutical regulatory requirements, biopharmaceutical manufacturing processes, and single-use system applications.
- Have proven experience in modeling, data-driven approaches, or digital tools, and the ability to translate science into business impact.
- Have excellent communication and influencing skills across diverse stakeholders, mentoring and relationship-building capabilities, problem-solving and decision-making skills in complex environments, autonomy, and scientific credibility.
- Be fluent in English.
- Define and execute the strategy for the Extractables & Leachables technology area in alignment with Product and Technology Roadmaps to influence business direction.
- Drive the evolution of science-based and proactive Extractables & Leachables approaches, moving beyond reactive compliance and reducing experimental burden through predictive methodologies.
- Develop and advance mechanistic and data-driven Extractables & Leachables methodologies, including predictive models and integration of toxicological data into risk and safety frameworks.
- Evaluate emerging industry trends, regulatory developments, and state-of-the-art technologies to identify innovation opportunities and guide scientific direction.
- Act as an internal and external Key Opinion Leader, contributing to industry consortia, regulatory initiatives, scientific publications, and conference presentations.
- Lead high-level technical discussions with customers and contribute to product qualification strategies, ensuring strong customer value creation and differentiation.
- Build and leverage internal and external networks, coach and mentor scientists, and ensure knowledge transfer across teams and functions.
- Additional language skills are desirable; the posting does not specify a language.
About the company
Sartorius is a global partner in life sciences research and biopharmaceutical manufacturing. It provides laboratories with innovative instruments and consumables for research and quality control, and it offers Bioprocess Solutions focused on single-use systems that help manufacture biotech medicines, vaccines, and cell- and gene- therapies safely, quickly, and cost-effectively. Its products support the full path from drug discovery to commercial manufacturing, with a large worldwide footprint of more than 60 sites and a mission to help more people access better medicines. Sartorius differentiates itself through its broad portfolio spanning lab and bioprocess needs, a strong emphasis on single-use technologies, continuous portfolio expansion via acquisitions, and deep expertise serving pharmaceutical, biotech, and academic customers. Its goal is to simplify progress from research and development to scalable manufacturing so that life-saving medicines can reach patients worldwide.
Company Size
5,001-10,000
Company Stage
IPO
Headquarters
Göttingen, Germany
Founded
1870
Get referred to Sartorius
See people who can refer or advise you
Simplify's Take
What believers are saying
- H1 2026 operational sales rose 7.7%, and management reaffirmed full-year guidance.
- May 2026 bond refinancing lowered funding pressure before the €650 million maturity.
- ElevateBio pilot validation and September 2026 ordering support Eveo sales conversion in 2027.
What critics are saying
- Tariff refunds and customer compensation cut 2026 revenue by up to €35 million.
- Lab Products grew only 5.3% operationally in H1 2026, lagging Bioprocess Solutions.
- Delayed advanced-therapy orders from two customers shift revenue into 2027, hurting execution confidence.
What makes Sartorius unique
- Eveo launches March 16, 2026, integrating cell therapy manufacturing and QC in one system.
- Bioprocess Solutions dominates with high-recurring consumables and switching costs across biologics manufacturing.
- Stedim Biotech integration gives Sartorius tighter control over single-use bioprocessing and global customer relationships.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- Dental Insurance
- Vision Insurance
- Life Insurance
- 401(k) Retirement Plan
- 401(k) Company Match
- Paid Vacation
- Paid Sick Leave
- Paid Holidays
- Flexible Work Hours
- Wellness Program
- Professional Development Budget